The hemodialys and peritoneal dialysis market demand is supposed to develop at a CAGR of 6.1%, from USD 81.8 billion out of 2022 to USD 148.1 billion by 2032. The rising number of ESRD patients, the rising commonness of diabetes and hypertension, the shortage of organ benefactors and the dangers related with transfers, mechanical headways, and drives …
Category Archives: Healthcare Trends
Gastrointestinal Stent Market value of around US$ 815.34 Million in 2033
By the end of 2022, the market for gastrointestinal stents will be worth US$ 455.44 million. The market is anticipated to grow at a CAGR of 5.5% from 2023 to 2033 and is projected to reach a market value of about US$ 815.34 Million in that year. As per the gastrointestinal stent market survey by Future Market Insights (FMI), the …
Continue reading “Gastrointestinal Stent Market value of around US$ 815.34 Million in 2033”
Manufacturers of Non-fusion Spinal Devices to Stand a Golden Chance as Consumers are Willing to Pay More for Better Hospital Experience | Market Anticipated to Rise at 4.8% CAGR
The global non fusion spinal devices market is predicted to register a CAGR of 4.8% over the forecast period, as per recent FMI analysis. The industry’s market valuation is anticipated to rise from US$ 4.37 billion in 2023 to US$ 6.99 billion by 2033 end. The non-fusion spinal devices industry is poised to attain a …
Lights for Dental Healthcare Market valuation of US$ 1.28 billion by the end of 2033
The market for lights used in dental care is expected to grow at a 5.7% CAGR, from a market valuation of US$ 704.4 million in 2022 to US$ 1.28 billion by the end of 2033. Despite the COVID-19 dilemma, the global demand for lights for dental healthcare, which was anticipated to be worth US$ 462.7 million in 2020, …
Arterial Cannula Market a CAGR of 6.6% in the forecast period 2023 to 2033
A recently published study by FMI expects the global arterial cannula market for arterial cannulas was valued at US$ 21 billion in 2023, and between 2022 to 2033, it is anticipated to grow at a CAGR of 6.6% to reach US$ 40 billion in market value. The 20-22 Fr is probably going to rule the market because …
Continue reading “Arterial Cannula Market a CAGR of 6.6% in the forecast period 2023 to 2033”
Genomics Market is expected to grow at a CAGR of 23% from 2022 to 2032
According to Future Market Insights’ newly released Genomics industry analysis report, According to Future Market Insights’ recently published analysis of the genomics market, global sales of genomics were estimated to reach $24.3 billion in 2021. The anticipated market growth from 2022 to 2032 is anticipated to be 19.8%, which will be much larger than the increase …
Continue reading “Genomics Market is expected to grow at a CAGR of 23% from 2022 to 2032”
Vitrectomy Devices Market is projected to US$ 2.6 billion by 2032
According to Future Market Insights’ newly released Vitrectomy Devices Market analysis report, According to a recently published industry study report by Future Market Insights, sales of vitrectomies devices were US$ 1.2 billion worldwide in 2021. The market is anticipated to grow at a CAGR of 7.3% from 2022 to 2032, reaching a worth of US$ 2.6 billion. The greatest …
Continue reading “Vitrectomy Devices Market is projected to US$ 2.6 billion by 2032”
Synthetic Biology Market is expected to reach US$ 138.8 Billion by 2032 to register a 24.3% CAGR
The global Synthetic Biology Market is expected to be worth US$ 15.8 billion by the end of 2022, and to grow at a CAGR of 24.3% to be worth US$ 138.8 billion by 2032. According to a recent study by Future Market Insights, the oligonucleotides segment by product will lead the market with a share of approximately …
Demand for Peripheral Vascular Devices Market in Europe is expected to register a 6.2% CAGR from 2022 to 2032
The global Peripheral Vascular Devices Market is expected to enjoy a valuation of US$ 4.7 Bn by the end of the year 2022, and further expand at a CAGR of 6.6% to reach a valuation of ~US$ 8.9 Bn by the year 2032. According to a recent study by Future Market Insights, peripheral vascular stents are leading the market with a share of …
Insulin Biosimilars Market | Eli Lilly & Co., Boehringer Ingelheim, Merck & Co., Pfizer Inc. | By 2032
The demand for Insulin Biosimilars Market is expected to reach US$ 1,468.6 million in 2022, rising at a CAGR of 14.9% to US$ 5,876.4 million from 2022 to 2032. Globally rising diabetic patient numbers are blamed for growth. A CAGR of 21.5% was recorded for the market for insulin biosimilars from 2016 to 2021. Biosimilar …